Omer N. Koç

5.8k total citations · 3 hit papers
57 papers, 4.5k citations indexed

About

Omer N. Koç is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Omer N. Koç has authored 57 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Pathology and Forensic Medicine and 18 papers in Hematology. Recurrent topics in Omer N. Koç's work include Hematopoietic Stem Cell Transplantation (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Omer N. Koç is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Omer N. Koç collaborates with scholars based in United States, Türkiye and Canada. Omer N. Koç's co-authors include Stanton L. Gerson, Hillard M. Lazarus, Stephen E. Haynesworth, Brenda Cooper, Emese Szekely, Arnold I. Caplan, Basabi Maitra, Mary J. Laughlin, Brian M. Davis and Pablo Rubinstein and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Omer N. Koç

53 papers receiving 4.4k citations

Hit Papers

Rapid Hematopoietic Recovery After Coinfusion of Autologo... 2000 2026 2008 2017 2000 2001 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
    2000 887 citations Omer N. Koç, Stanton L. Gerson et al. profile →
  2. Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
    2001 643 citations Mary J. Laughlin, Juliet N. Barker et al. New England Journal of Medicine profile →
  3. Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients
    2005 607 citations Hillard M. Lazarus, Omer N. Koç et al. Biology of Blood and Marrow Transplantation profile →

Peers

Omer N. Koç
Ida Rasmusson Sweden
Mehmet Uzunel Sweden
Lynne M. Ball Netherlands
Annemarie Moseley United States
Cecilia Götherström Sweden
Jean‐Jacques Lataillade France
Pierre Charbord France
Paola Matteucci Italy
Benedetto Sacchetti Italy
Helene Roelofs Netherlands
Ida Rasmusson Sweden
Omer N. Koç
Citations per year, relative to Omer N. Koç Omer N. Koç (= 1×) peers Ida Rasmusson

Countries citing papers authored by Omer N. Koç

Since Specialization
Citations

This map shows the geographic impact of Omer N. Koç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omer N. Koç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omer N. Koç more than expected).

Fields of papers citing papers by Omer N. Koç

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omer N. Koç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omer N. Koç. The network helps show where Omer N. Koç may publish in the future.

Co-authorship network of co-authors of Omer N. Koç

This figure shows the co-authorship network connecting the top 25 collaborators of Omer N. Koç. A scholar is included among the top collaborators of Omer N. Koç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omer N. Koç. Omer N. Koç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yılmaz, Vuslat, et al.. (2025). P0385 Delayed Diagnosis in Inflammatory Bowel Disease in Turkish Population. Journal of Crohn s and Colitis. 19(Supplement_1). i873–i874.
2.
Koç, Omer N., et al.. (2024). Forecasting of the Unemployment Rate in Turkey: Comparison of the Machine Learning Models. Sustainability. 16(15). 6509–6509. 3 indexed citations
3.
Hill, Brian T., Deepa Jagadeesh, Alex Garcia, et al.. (2020). Results of a Phase I Trial of Lenalidomide, Rituximab (R2) and Ixazomib for Frontline Treatment of High Risk Follicular and Indolent Non-Hodgkin Lymphoma. Blood. 136(Supplement 1). 1–2. 1 indexed citations
4.
Ilaslan, Hakan, et al.. (2010). Sacroiliac joint dysfunction. Turkish Neurosurgery. 20(3). 398–401. 9 indexed citations
5.
Naderi, Sait, Hakan Ilaslan, Ahmet Aslan, Omer N. Koç, & Türker Dalkılıç. (2009). Sacroplasty: report of three cases. Turkish Neurosurgery. 20(3). 418–22. 4 indexed citations
6.
Bhakta, Shyam, Ping Hong, & Omer N. Koç. (2006). The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovascular revascularization medicine. 7(1). 19–24. 111 indexed citations
7.
Yüksel, Meltem Kurt, Elma D. Baron, Melissa Camouse, et al.. (2006). Peritransplant Use of Ultraviolet-B Irradiation (UV-B) Therapy Is Detrimental to Allogeneic Stem Cell Transplantation Outcome. Biology of Blood and Marrow Transplantation. 12(6). 665–671. 8 indexed citations
8.
Heeckeren, Willem J. van, Pingfu Fu, Brenda Cooper, et al.. (2005). Randomised comparison of two B‐cell purging protocols for patients with B‐cell non‐Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34+ cell enrichment device. British Journal of Haematology. 132(1). 42–55. 22 indexed citations
9.
Bahlis, Nizar J., et al.. (2005). N-Benzoylstaurosporine (PKC412) inhibits Akt kinase inducing apoptosis in multiple myeloma cells. Leukemia & lymphoma. 46(6). 899–908. 17 indexed citations
10.
O’Connor, Owen A., James R. Wright, Craig H. Moskowitz, et al.. (2004). A Multicenter Experience with Single Agent Bortezomib in Non-Hodgkin’s Lymphoma Reveals Marked Differences in Sub-Type Sensitivity to Proteasome Inhibition.. Blood. 104(11). 607–607. 16 indexed citations
11.
Meyerson, Howard, et al.. (2004). A sustained response to low dose interferon‐α in a case of refractory pure red cell aplasia. European Journal Of Haematology. 73(4). 300–303. 3 indexed citations
12.
Nihal, Minakshi, Debra Mikkola, Omer N. Koç, et al.. (2003). Folliculotropic mycosis fungoides with central nervous system involvement: Demonstration of tumor clonality in intrafollicular T cells using laser capture microdissection. Journal of the American Academy of Dermatology. 48(2). 238–243. 11 indexed citations
13.
Wadhwa, Punit D., Hillard M. Lazarus, Omer N. Koç, et al.. (2003). Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration. Leukemia Research. 27(3). 215–220. 12 indexed citations
14.
Lee, Keunmyoung, Stanton L. Gerson, Basabi Maitra, & Omer N. Koç. (2001). G156A MGMT-Transduced Human Mesenchymal Stem Cells Can Be Selectively Enriched by O 6 -Benzylguanine and BCNU. Journal of Hematotherapy & Stem Cell Research. 10(5). 691–701. 12 indexed citations
15.
Laughlin, Mary J., Juliet N. Barker, Barbara Bambach, et al.. (2001). Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors. New England Journal of Medicine. 344(24). 1815–1822. 643 indexed citations breakdown →
16.
Reese, Jane, Omer N. Koç, & Stanton L. Gerson. (1999). Human Mesenchymal Stem Cells Provide Stromal Support for Efficient CD34 + Transduction. Journal of Hematotherapy & Stem Cell Research. 8(5). 515–523. 27 indexed citations
17.
18.
19.
Oo, Maung Maung, Leila A. Kutteh, Omer N. Koç, Melvin Strauss, & Hillard M. Lazarus. (1998). Mucormycosis of Petrous Bone in an Allogeneic Stem Cell Transplant Recipient. Clinical Infectious Diseases. 27(6). 1546–1547. 9 indexed citations
20.
Koç, Omer N., et al.. (1996). Role of DNA Repair in Resistance to Drugs that Alkylate O6 of Guanine. Cancer treatment and research. 87. 123–146. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ida Rasmusson Breakdown of academic impact, for papers by Mehmet Uzunel Breakdown of academic impact, for papers by Lynne M. Ball Breakdown of academic impact, for papers by Annemarie Moseley Breakdown of academic impact, for papers by Cecilia Götherström Breakdown of academic impact, for papers by Jean‐Jacques Lataillade Breakdown of academic impact, for papers by Pierre Charbord Breakdown of academic impact, for papers by Paola Matteucci Breakdown of academic impact, for papers by Benedetto Sacchetti Breakdown of academic impact, for papers by Helene Roelofs
Rankless by CCL
2026